Inventor · disambiguated record
Scott L. Harbeson
Also filed as: HARBESON PH D SCOTT L · HARBESON SCOTT · HARBESON SCOTT L
60 granted patents·42 pending applications·1,005 citations·filing 1993–2024
98Inventor score
Files withCONCERT PHARMACEUTICALS INC49HARBESON SCOTT L21VERTEX PHARMA7LIU JULIE F5MERRELL PHARMA INC4
Top patents by PatentIndex Score
102 records- 0198US9249149B2Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2015·Granted Feb 2, 2016·62 cites·15 claims
- 0297US8987442B2Deuterium-substituted xanthine derivatives and methods of useTUNG ROGER D·Filed 2012·Granted Mar 24, 2015·53 cites·38 claims
- 0397US7528131B2Substituted morpholinyl compoundsCONCERT PHARMACEUTICALS INC·Filed 2008·Granted May 5, 2009·253 cites·11 claims
- 0497US6617309B2Inhibitors of serine proteases, particularly hepatitis C virus NS3 proteaseVERTEX PHARMA·Filed 2001·Granted Sep 9, 2003·103 cites·32 claims
- 0597US6265380B1Inhibitors of serine proteases, particularly hepatitis C virus NS3 proteaseVERTEX PHARMA·Filed 1999·Granted Jul 24, 2001·200 cites·36 claims
- 0696US7388017B2Inhibitors of serine proteases, particularly hepatitis C virus NS3 proteaseVERTEX PHARMA·Filed 2003·Granted Jun 17, 2008·77 cites·41 claims
- 0795US8263601B2Deuterium substituted xanthine derivativesTUNG ROGER D·Filed 2010·Granted Sep 11, 2012·28 cites·27 claims
- 0892US8563554B2Deuterated pyrazinoisoquinoline compoundsLIU JULIE F·Filed 2010·Granted Oct 22, 2013·8 cites·3 claims
- 0991US8354557B2Synthesis of deuterated morpholine derivativesCONCERT PHARMACEUTICALS INC·Filed 2009·Granted Jan 15, 2013·9 cites·8 claims
- 1088US8003646B2Substituted triazolo-pyridazine derivativesCONCERT PHARMACEUTICALS INC·Filed 2009·Granted Aug 23, 2011·7 cites·9 claims
- 1188US7271179B2Inhibitors of JAK protein kinaseVERTEX PHARMA·Filed 2003·Granted Sep 18, 2007·32 cites·21 claims
- 1287US9035050B2Substituted xanthine derivativesCONCERT PHARMACEUTICALS INC·Filed 2013·Granted May 19, 2015·7 cites·22 claims
- 1387US8278460B2Substituted benzimidazolesLIU JULIE F·Filed 2010·Granted Oct 2, 2012·10 cites·5 claims
- 1487US2025025467A1Deuterated derivatives of ruxolitinibSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 1586US7943620B2Anti-anginal compoundsCONCERT PHARMACEUTICALS INC·Filed 2008·Granted May 17, 2011·8 cites·31 claims
- 1685US8796267B2Oxazolidinone derivatives and methods of useTUNG ROGER·Filed 2008·Granted Aug 5, 2014·4 cites·10 claims
- 1785US7687509B2Pyrimidinecarboxamide derivativesCONCERT PHARMACEUTICALS INC·Filed 2008·Granted Mar 30, 2010·6 cites·9 claims
- 1884US7157476B2Aminofurazan compounds useful as protein kinase inhibitorsVERTEX PHARMA·Filed 2004·Granted Jan 2, 2007·22 cites·10 claims
- 1982US8314141B2Inhibitors of serine proteases, particularly hepatitis C virus NS3 proteaseTUNG ROGER D·Filed 2008·Granted Nov 20, 2012·3 cites·9 claims
- 2082US2023355629A1Deuterated derivatives of ruxolitinibSUN PHARMACEUTICAL IND INC·Filed 2022·Application pending·0 cites
- 2181US9492457B2Substituted xanthine derivativesCONCERT PHARMACEUTICALS INC·Filed 2015·Granted Nov 15, 2016·2 cites·18 claims
- 2281US9206179B2Methods of use comprising deuterated pyrazino[2,1-a]isoquinolinesCONCERT PHARMACEUTICALS INC·Filed 2014·Granted Dec 8, 2015·1 cites·21 claims
- 2381US8952016B2Substituted xanthine derivativesTUNG ROGER D·Filed 2010·Granted Feb 10, 2015·5 cites·8 claims
- 2480US9694017B2Substituted triazolobenzodiazepinesCONCERT PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·2 cites·12 claims
- 2580US9493463B2Substituted xanthine derivativesCONCERT PHARMACEUTICALS INC·Filed 2015·Granted Nov 15, 2016·2 cites·21 claims
- 2680US8889687B2Deuterated pyrazinoisoquinoline compoundsLIU JULIE F·Filed 2012·Granted Nov 18, 2014·3 cites·4 claims
- 2780US8399467B2Substituted triazolo-pyridazine derivativesHARBESON SCOTT L·Filed 2011·Granted Mar 19, 2013·3 cites·9 claims
- 2880US7820666B2Tetrahydrotriazolopyrazine derivatives and uses thereofCONCERT PHARMACEUTICALS INC·Filed 2008·Granted Oct 26, 2010·3 cites·19 claims
- 2978US8198305B21,2-benzisoxazol-3-yl compoundsHARBESON SCOTT L·Filed 2008·Granted Jun 12, 2012·3 cites·9 claims
- 3077US10039769B2Substituted triazolobenzodiazepinesCONCERT PHARMACEUTICALS INC·Filed 2017·Granted Aug 7, 2018·1 cites·14 claims
- 3177US9918987B2Substituted xanthine derivativesCONCERT PHARMACEUTICALS INC·Filed 2016·Granted Mar 20, 2018·1 cites·18 claims
- 3277US9328113B2Substituted xanthine derivativesCONCERT PHARMACEUTICALS INC·Filed 2013·Granted May 3, 2016·3 cites·9 claims
- 3376US7994194B24-oxoquinoline derivativesCONCERT PHARMACEUTICALS INC·Filed 2008·Granted Aug 9, 2011·2 cites·8 claims
- 3475US9676790B2Substituted thienotriazolodiazapinesCONCERT PHARMACEUTICALS INC·Filed 2014·Granted Jun 13, 2017·1 cites·26 claims
- 3574US8921366B2Substituted triazolo-pyridazine derivativesCONCERT PHARMACEUTICALS INC·Filed 2013·Granted Dec 30, 2014·1 cites·9 claims
- 3674US2021330674A1Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3773US9199986B2Deuterated pyrazino[2,1-a]isoquinolines for the treatment of diseases and/or conditionsCONCERT PHARMACEUTICALS INC·Filed 2013·Granted Dec 1, 2015·1 cites·14 claims
- 3872US9783528B2Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferaseCONCERT PHARMACEUTICALS INC·Filed 2015·Granted Oct 10, 2017·1 cites·20 claims
- 3971US5541290AOptically pure calpain inhibitor compoundsFiled 1993·Granted Jul 30, 1996·43 cites·13 claims
- 4069US8592487B2Deuterated darunavirHARBESON SCOTT L·Filed 2009·Granted Nov 26, 2013·0 cites·9 claims
- 4169US8410082B2Fluorinated diaryl urea derivativesLIU JULIE F·Filed 2010·Granted Apr 2, 2013·1 cites·10 claims
- 4269US8318754B2Pyrimidinecarboxamide derivativesHARBESON SCOTT L·Filed 2010·Granted Nov 27, 2012·1 cites·20 claims
- 4368US2019308976A1Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4466US10335413B2Substituted xanthine derivativesCONCERT PHARMACEUTICALS INC·Filed 2018·Granted Jul 2, 2019·0 cites·20 claims
- 4566US9453009B2Synthesis of deuterated morpholine derivativesCONCERT PHARMACEUTICALS INC·Filed 2014·Granted Sep 27, 2016·0 cites·5 claims
- 4666US8349817B2Analogues of cilostazolCONCERT PHARMACEUTICALS INC·Filed 2009·Granted Jan 8, 2013·0 cites·8 claims
- 4766US2015197525A1Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4865US2009036357A1Azapeptide derivativesCONCERT PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4964US2009239886A1Substituted xanthine derivativesCONCERT PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 5063US2015111895A1Substituted triazolo-pyridazine derivativesCONCERT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 102 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Scott L. Harbeson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →